Sort by
Refine Your Search
-
a postdoctoral fellow to study the cell fate decision mechanisms in hematopoietic stem and multipotent progenitor cells using primary mouse and human bone marrow cells and patient samples
-
microenvironment contexts and how to exploit these phenotypes. To do this, we are employing mouse models of PDA, analyses in human specimens, multiomics and CRISPR-Cas9 engineering. Ongoing projects: * Define
-
Position Summary Dr. Amargant-Riera’s research laboratory focuses on understanding the mechanisms that define oocyte quality. The lab uses mouse models and human samples to investigate
-
to various therapies in combination to standard of care treatments. We take a “bedside to bench” approach leveraging access to human tumor samples, genomic sequencing technologies, state-of-the-art high
-
and organ signaling pathways in IBD (including Crohn’s disease and ulcerative colitis) using molecular and cell biology, multi-omics technologies, murine models, and human tissues. We currently have
-
of Medicine. The Millman biomedical research laboratory uses embryonic and induced human pluripotent stem cells for the study and treatment of diabetes. We have a wide diversity of projects involving stem cells
-
leveraging state-of-the-art recording technologies in both humans and rodents. As we are a new research group, the successful candidate will have the opportunity to help shape the lab's research direction and